 | Up a level |
Despierre, Evelyn, Vergote, Ignace, Anderson, Ryan, Coens, Corneel, Katsaros, Dionyssios, Hirsch, Fred R, Boeckx, Bram, Varella-Garcia, Marileila, Ferrero, Annamaria, Ray-Coquard, Isabelle et al (show 6 more authors)
(2016)
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy (vol 10, pg 583, 2015).
TARGETED ONCOLOGY, 11 (3).
p. 429.
von Euler, Mikael, Wiman, Klas G, Gabra, Hani, Brenton, James D, Basu, Bristi, Vergote, Ignace, Gourley, Charlie, Smith, Austin, Alfredsson, Jessica, Mohelll, Nina et al (show 1 more authors)
(2015)
Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer.
In: Clinical Trials.